# IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage

> **NCT05045417** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 140 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DIAGNOSTIC_TEST:** Serum level of IL-17

## Key facts

- **NCT ID:** NCT05045417
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045417, "IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05045417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*